Different levels of HIV DNA copy numbers in cerebrospinal fluid cellular subsets

Journal of Health Care for the Poor and Underserved

Volumn 24, Issue 4 SUPPL., 2013, Pages 8-16

  Agsalda Garcia, Melissa ^a   Shiramizu, Bruce ^a   Melendez, Loyda ^b   Plaud, Marines ^b   Liang, Chin Yuan ^a   Wojna, Valerie ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Cerebrospinal fluid (CSF); Choroid plexus; HIV DNA; HIV associated neurocognitive disorders (HAND)

Indexed keywords

CD14 ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; PUERTO RICO; UNITED STATES;

ADULT; ANTIGENS, CD14; COGNITION DISORDERS; COHORT STUDIES; DNA, VIRAL; FEMALE; HAWAII; HIV INFECTIONS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; PUERTO RICO; SAMPLING STUDIES;

EID: 84887640094     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2014.0010     Document Type: Article

References (34)

1. Centers for Diease Control and Prevention (CDC). Geographic differences in HIV infection among Hispanics or Latinos-46 states and Puerto Rico, 2010. MMWR Morb Mortal Wkly Rep, 2012 Oct 12. 61(40):805-10.
2. Centers for Disease Control and Prevention (CDC). HIV surveillance report: diagnoses of HIV infection and AIDS in the United States and dependent areas, 2010. Atlanta, GA: CDC, 2010. Available at: http://www.cdc.gov/hiv/surveillance/resources/reports/2010report/pdf/2010_HIV_Surveillance_Report_vol_22.pdf.
3. Thames AD, Moizel J, Panos SE, et al. Differential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV- positive drug- using adults. AIDS Patient Care STDS. 2012 Oct;26(10):621-30.Epub 2012 Aug 13.
4. Maki PM, Martin-Thormeyer E. HIV, cognition and women. Neuropsychol Rev. 2009 Jun 19(2):204-214.Epub 2009 May 9.
5. Richardson MA, Morgan EE, Viehauer MJ, et al. Utility of the HIV dementia scale in assessing risk for signif cant HIV- related cognitive- motor deficits in a high- risk urban adult sample. AIDS Care. 2005 Nov;17(8):1013-1021.
6. Wojna V, Skolasky RL, Hechavarria R, et al. Prevalence of human immunodeficiency virus- associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol. 2006 Oct;12(5):356-364.
7. Antinori A, Arendt G, Becker et al., Updated research nosology for HIV- associated neurocognitive disorders. Neurology. 2007 Oct 30;69(18):1789-1799.Epub 2007 Oct 3.
8. Levine AJ, Miller JA, Shapshak P, et al. Systems analysis of human brain gene expression: mechanisms for HIV- associated neurocognitive impairment and common pathways with Alzheimer's disease. BMC Med Genomics. 2013 Feb 13,6:4.
9. Valcour V, Chalermchai T, Sailasuta N, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012 Jul 15;206(2):275-282.Epub 2012 May 2.
10. Zhang Y, Wang M, Li H, et al. Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV- associated neurocognitive disorders. Brain Res. 2012 Jun 6;1458:1-11.Epub 2012 Apr 11.
11. Pulliam L, Gascon R, Stubblebine M, et al. Unique monocyte subset in patients with AIDS dementia. Lancet. 1997 Mar 8;349(9053):692-695.
12. Ellery PJ, Tippett E, Chiu YL, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV- 1 in vivo. J Immunol. 2007 May;178(10):6581-6589.
13. González- Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005 Jan;5(1):69-81.
14. Jaworowski A, Kamwendo DD, Ellery P, et al. CD16+ monocyte subset preferentially harbors HIV- 1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV- 1 infection. J Infect Dis. 2007 Jul 1;196(1):38-42.Epub 2007 May 16.
15. Neuenburg JK, Furlan S, Bacchetti P, et al. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS. 2005 Sep 2;19(13)1351-1359.
16. Alexaki A, Wigdahl B. HIV- 1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog. 2008 Dec;4(12):e1000215.Epub 2008 Dec 26.
17. Bering EA Jr. Circulation of the cerebrospinal fluid. Demonstration of the choroid plexuses as the generator of the force for flow of fluid and ventricular enlargement. J Neurosurg. 1962 May;19:405-413.
18. Clay CC, Rodriques DS, Ho YS, et al. Neuroinvasion of f uorescein- positive monocytes in acute simian immunodef ciency virus infection. J Virol. 2007 Nov;81(21):12040-12048. Epub 2007 Aug 22.
19. Symss N P, Oi S. Theories of cerebrospinal fluid dynamics and hydrocephalus: historical trend. J Neurosurg Pediatr. 2013 Feb;11(2):170-177.Epub 2012 Dec 7.
20. Schnell G, Spudich S, Harrington P, et al. Compartmentalized human immunodeficiency virus type 1 originates from long- lived cells in some subjects with HIV- 1-associated dementia. PLoS Pathog. 2009 Apr;5(4):e1000395.Epub 2009 Apr 24.
21. Letendre S, Marquie- Beck J, Capparelli E, et al. Validation of the CNS Penetration-Effeectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008 Jan;65(1):65-70.
22. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV- 1 individuals: the Hawaii Aging with HIV- 1 Cohort. Neurology. 2004 Sep 14; 63(5):822-827.
23. Janssen RS, Cornblath DR, Epstein LG, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus- type 1 (HIV-1) infection. Neurology, 1991;41:778-785.
24. Wojna V, Nath A. Challenges to the diagnosis and management of HIV dementia. AIDS Read. 2006 Nov;16(11):615-616, 621-4, 626, 629-32.
25. Kusao I, Shiramizu B, Liang CY, et al. Cognitive performance related to HIV- 1- infected monocytes. J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):71-80.
26. Letendre SL, Ellis RJ, Ances BM, et al. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2010 Apr-May;18(2):45-55.
27. Kivisakk P, Mahad DJ, Callahan MK, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for traf cking through choroid plexus and meninges via P- selectin. Proc Natl Acad Sci USA. 2003 Jul 8;100(14):8389-8394.Epub 2003 Jun 26.
28. Mitchell K, Yan HY, Berk JD, et al. Monocyte chemoattractant protein- 1 in the choroid plexus: a potential link between vascular pro- inflammatory mediators and the CNS during peripheral tissue inflammation. Neuroscience. 2009 Jan 23;158(2):885-895.Epub 2008 Nov 7.
29. Burkala EJ, He J, West JT, et al. Compartmentalization of HIV- 1 in the central nervous system: role of the choroid plexus. AIDS. 2005 Apr 29;19(7):675-684.
30. Caragounis EC, Gisslen M, Lindh M, et al. Comparison of HIV- 1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante- mortem and post- mortem. Acta Neurol Scand. 2008 Feb;117(2):108-16.
31. Harrington PR, Schnell G, Letendre SL, et al. Cross-sectional characterization of HIV- 1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS. 2009 May;23(8):907-15.
32. Schnell G, Joseph S, Spudich S, et al. HIV- 1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog. 2011 Oct 7(10):e1002286.Epub 2011 Oct 6.
33. Clements JE, Li M, Gama L, et al. The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active anti-retroviral therapy. J Neurovirol. 2005 Apr;11(2):180-9.
34. Churchill M, Nath A. Where does HIV hide? A focus on the central nervous system. Curr Opin HIV AIDS. 2013 May;8(3):165-9.